- News Home
10 April 2014 11:44 am ,
Vol. 344 ,
The Pyrenean ibex, an impressive mountain goat that lived in the central Pyrenees in Spain, went extinct in 2000. But a...
Tight budgets are forcing NASA to consider turning off one or more planetary science projects that have completed their...
Ebola is not a stranger to West Africa—an outbreak in the 1990s killed chimpanzees and sickened one researcher. But the...
In an as-yet-unpublished report, an international panel of geoscientists has concluded that a pair of deadly...
Tropical disease experts tried and failed before to eradicate yaws, a rare disfiguring disease of poor countries. Now,...
Since 2002, researchers have reported that agricultural communities in the hot and humid Pacific Coast of Central...
Balkan endemic kidney disease surfaced in the 1950s and for decades defied attempts to finger the cause. It occurred...
- 10 April 2014 11:44 am , Vol. 344 , #6180
- About Us
Grassley to NIH: Crack the Whip
20 November 2008 2:14 pm
Expect no letup in the investigation of U.S. biomedical researchers who violate conflict-of-interest regulations. So says Senator Chuck Grassley (R–IA), who’s been hammering scientists who receive pay from drug companies but fail to comply with U.S. rules requiring them to report such outside income. In a conversation on 19 November, Grassley told Science that the National Institutes of Health (NIH) needs to be more aggressive about getting the universities and researchers it funds to disclose consulting income. The Iowa lawmaker is concerned that NIH's plan to revise the reporting rules is an excuse for inaction. That could take a couple of years, Grassley says. "They can change [the rules] if they want to, but ... they've got plenty of leverage with just yanking back grants," he says.
One institution has already suffered that fate—Emory University in Atlanta, which had an NIH grant suspended after Grassley’s inquiry identified a psychiatry department chair who had allegedly not properly reported some income. Grassley staffers say that some universities—such as Stanford in Palo Alto, California—have told investigators that they have seen no significant lapses. But a Harvard University inquiry is “ongoing,” Senate aides say—and likely to make news again.